• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏手术后的凝血功能障碍可能受功能性纤溶酶原激活物抑制剂基因多态性的影响。

Coagulopathy after cardiac surgery may be influenced by a functional plasminogen activator inhibitor polymorphism.

作者信息

Duggan Edel, O'Dwyer Michael J, Caraher Emma, Diviney Dara, McGovern Eilis, Kelleher Dermot, McManus Ross, Ryan Thomas

机构信息

Department of Anaesthesia, Trinity Centre for Health Sciences, St. James's Hospital, Dublin, Ireland.

出版信息

Anesth Analg. 2007 Jun;104(6):1343-7, table of contents. doi: 10.1213/01.ane.0000261267.28891.00.

DOI:10.1213/01.ane.0000261267.28891.00
PMID:17513622
Abstract

BACKGROUND

Cytokine-mediated inflammation and coagulopathy may occur after cardiac surgery. In this study we investigated the temporal pattern of plasminogen activator inhibitor-1 (PAI-1) gene expression after cardiac surgery and its relation with PAI genotype, and obtained preliminary data regarding its relation to perioperative morbidity.

METHODS

The relative change in PAI-1 mRNA 1, 6, and 24 h after cardiopulmonary bypass (CPB) was measured from mononuclear cells in 82 patients undergoing elective cardiac surgery. DNA was analyzed for carriage of the 4G/5G PAI-1 polymorphism.

RESULTS

PAI-1 gene expression decreased after CPB in all patients. A larger reduction in PAI-1 gene expression was observed in homozygous carriers of the 5G allele. Homozygous carriers of the 5G allele were also more likely to receive transfusion of coagulation blood products. There was no relation between change in PAI-1 gene expression and duration of CPB.

CONCLUSIONS

PAI-1 gene expression decreased over time after CPB. We found a link between PAI-1 genotype, PAI gene expression, and transfusion of coagulation products after cardiac surgery.

摘要

背景

心脏手术后可能会发生细胞因子介导的炎症和凝血病。在本研究中,我们调查了心脏手术后纤溶酶原激活物抑制剂-1(PAI-1)基因表达的时间模式及其与PAI基因型的关系,并获得了有关其与围手术期发病率关系的初步数据。

方法

从82例行择期心脏手术患者的单核细胞中测量体外循环(CPB)后1、6和24小时PAI-1 mRNA的相对变化。分析DNA以检测4G/5G PAI-1多态性的携带情况。

结果

所有患者CPB后PAI-1基因表达均下降。在5G等位基因纯合携带者中观察到PAI-1基因表达有更大程度的降低。5G等位基因纯合携带者也更有可能接受凝血血液制品的输血。PAI-1基因表达的变化与CPB持续时间之间没有关系。

结论

CPB后PAI-1基因表达随时间下降。我们发现了PAI-1基因型、PAI基因表达与心脏手术后凝血制品输血之间的联系。

相似文献

1
Coagulopathy after cardiac surgery may be influenced by a functional plasminogen activator inhibitor polymorphism.心脏手术后的凝血功能障碍可能受功能性纤溶酶原激活物抑制剂基因多态性的影响。
Anesth Analg. 2007 Jun;104(6):1343-7, table of contents. doi: 10.1213/01.ane.0000261267.28891.00.
2
Postoperative bleeding in cardiac surgery: the role of tranexamic acid in patients homozygous for the 5G polymorphism of the plasminogen activator inhibitor-1 gene.心脏手术中的术后出血:氨甲环酸在纤溶酶原激活物抑制剂-1基因5G多态性纯合患者中的作用
Anesthesiology. 2008 Apr;108(4):596-602. doi: 10.1097/ALN.0b013e318167aecc.
3
PAI-1 gene: pharmacogenetic association of 4G/4G genotype with bleeding after cardiac surgery--pilot study.纤溶酶原激活物抑制剂-1基因:4G/4G基因型与心脏手术后出血的药物遗传学关联——初步研究
Eur J Anaesthesiol. 2009 May;26(5):404-11. doi: 10.1097/EJA.0b013e3283240412.
4
The -675 4G/5G polymorphism at the Plasminogen Activator Inhibitor 1 (PAI-1) gene modulates plasma Plasminogen Activator Inhibitor 1 concentrations in response to dietary fat consumption.纤溶酶原激活物抑制剂1(PAI-1)基因的-675 4G/5G多态性可调节血浆纤溶酶原激活物抑制剂1的浓度,以应对膳食脂肪摄入。
Br J Nutr. 2008 Apr;99(4):699-702. doi: 10.1017/S0007114507831710. Epub 2007 Oct 1.
5
Influence of the 4G/5G PAI-1 genotype on angiotensin II-stimulated human endothelial cells and in patients with hypertension.4G/5G纤溶酶原激活物抑制因子-1基因型对血管紧张素II刺激的人内皮细胞及高血压患者的影响。
Cardiovasc Res. 2004 Jul 1;63(1):176-85. doi: 10.1016/j.cardiores.2004.03.023.
6
Plasminogen activator inhibitor 1 expression in platelets is not influenced by the 4G/5G promoter polymorphism.血小板中纤溶酶原激活物抑制剂1的表达不受4G/5G启动子多态性的影响。
Thromb Res. 2008;121(6):793-7. doi: 10.1016/j.thromres.2007.07.018. Epub 2007 Sep 19.
7
PAI-1 Gene 4G/5G polymorphism and risk of type 2 diabetes in a population-based sample.基于人群样本的纤溶酶原激活物抑制剂-1(PAI-1)基因4G/5G多态性与2型糖尿病风险
Obesity (Silver Spring). 2006 May;14(5):753-8. doi: 10.1038/oby.2006.85.
8
Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism and endometriosis. Influence of PAI-1 polymorphism on PAI-1 antigen and mRNA expression.纤溶酶原激活物抑制剂-1(PAI-1)4G/5G多态性与子宫内膜异位症。PAI-1多态性对PAI-1抗原及mRNA表达的影响。
Thromb Res. 2008;122(6):854-60. doi: 10.1016/j.thromres.2008.02.010. Epub 2008 Apr 18.
9
Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer among men with a positive family history.纤溶酶原激活物抑制剂1型(PAI-1)基因多态性4G/5G与有家族史男性的前列腺癌相关。
Prostate. 2007 Feb 1;67(2):172-7. doi: 10.1002/pros.20512.
10
Plasminogen activator inhibitor -1 gene 4G/5G polymorphism in patients with breast cancer.乳腺癌患者纤溶酶原激活物抑制剂-1基因4G/5G多态性
J BUON. 2006 Oct-Dec;11(4):481-4.

引用本文的文献

1
Polymorphisms on PAI-1 and ACE genes in association with fibrinolytic bleeding after on-pump cardiac surgery.纤溶酶原激活物抑制剂-1(PAI-1)和血管紧张素转换酶(ACE)基因多态性与心脏搭桥术后纤溶出血的相关性
BMC Anesthesiol. 2015 Sep 4;15:122. doi: 10.1186/s12871-015-0101-1.
2
PAI-1 and t-PA/PAI-1 complex potential markers of fibrinolytic bleeding after cardiac surgery employing cardiopulmonary bypass.心脏体外循环手术后纤溶出血的 PAI-1 和 t-PA/PAI-1 复合物潜在标志物。
BMC Anesthesiol. 2012 Oct 30;12:27. doi: 10.1186/1471-2253-12-27.
3
Continuous localized monitoring of plasmin activity identifies differential and regional effects of the serine protease inhibitor aprotinin: relevance to antifibrinolytic therapy.
持续局部监测纤溶酶活性可识别丝氨酸蛋白酶抑制剂抑肽酶的差异和区域作用:与抗纤维蛋白溶解治疗的相关性。
J Cardiovasc Pharmacol. 2011 Apr;57(4):400-6. doi: 10.1097/FJC.0b013e31820b7df1.
4
Blood management-issues: the panic of coagulopathic bleeding--is there a rational approach?血液管理问题:凝血病性出血的恐慌——是否存在合理的应对方法?
J Extra Corpor Technol. 2011 Mar;43(1):P58-64.
5
Interstitial plasmin activity with epsilon aminocaproic acid: temporal and regional heterogeneity.伴用 ε-氨基己酸的间质纤维蛋白溶酶活性:时间和区域异质性。
Ann Thorac Surg. 2010 May;89(5):1538-45. doi: 10.1016/j.athoracsur.2010.01.051.
6
Genomics: risk and outcomes in cardiac surgery.基因组学:心脏手术中的风险与预后
Anesthesiol Clin. 2008 Sep;26(3):399-417. doi: 10.1016/j.anclin.2008.04.002.
7
Impact of genetic variation on perioperative bleeding.基因变异对围手术期出血的影响。
Am J Hematol. 2008 Sep;83(9):732-7. doi: 10.1002/ajh.21205.